The challenges of economic evaluation of drugs for rare diseases and thoughts of its countermeasures in China

HU Jiahao, KANG Qi, ZHU Lin, LIU Yuhan, HOU Xiaohui, HE Jiangjiang, JIN Chunlin

PDF(1668 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(1668 KB)
World Clinical Drug ›› 2022, Vol. 43 ›› Issue (02) : 109-114. DOI: 10.13683/j.wph.2022.02.001
Topic

The challenges of economic evaluation of drugs for rare diseases and thoughts of its countermeasures in China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 43(02): 109-114 https://doi.org/10.13683/j.wph.2022.02.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1668 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉